Observed Signal · Oct 27, 2026 · Funding · Source: Trending Topics (DACH/CEE Innovation & Tech) · Impact: 3/5 · Sentiment: Positive
Deutsche Telekom and LG Back Tandem Health's AI Assistant
Swedish health tech startup Tandem Health has secured strategic investors for its ongoing Series B round: T.Capital, the investment arm of Deutsche Telekom, LG Technology Ventures, and impact fund Norrsken VC, though the amount was undisclosed. Tandem provides an AI medical assistant that automates clinical documentation, coding, and decision support, with three products certified as Class IIa medical devices. The company has raised about $160M total, including a $100M Series B led by EQT's Scaleup Europe Fund, and serves 10,000 care organizations across 14 countries, including the NHS, Ramsay Santé, and Humanitas. The strategic investors offer access to health systems: T-Systems' record systems are in over 250 hospitals, LG supplies European care providers, and Norrsken focuses on health impact. Tandem plans to expand its AI-native clinic operating system and give European clinicians one billion hours back.
This funding round highlights increasing strategic investment in AI-driven healthcare solutions, with major corporate investors from telecom and tech sectors, signaling growth and validation for AI clinical documentation tools.
Track Deutsche Telekom Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Tandem Health raised $100M in Series B led by EQT's Scaleup Europe Fund, with total funding of ~$160M including a $50M Series A.
- T.Capital (Deutsche Telekom), LG Technology Ventures, and Norrsken VC joined as strategic investors in the Series B; investment amount undisclosed.
- Tandem's AI assistant is used by 10,000 healthcare facilities in 14 countries, including the NHS, Ramsay Santé, and Humanitas.
- Three of Tandem's products are certified as Class IIa medical devices under EU law.
- Tandem acquired Dutch AI scribe Juvoly earlier this year.
Connected Companies & Entities
7 Entities mapped“Parent company of T.Capital, which invested in Tandem Health's Series B.”
“Participated in Tandem Health's Series B round.”
“Strategic investor via LG Technology Ventures and supplier of products to healthcare institutions.”
“Former employer of two Tandem founders.”
“Competitor with its Dragon Copilot for clinicians.”
“Swedish investment firm that manages the Scaleup Europe Fund, which led Tandem's $100M Series B.”
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Tandem Health Raises $100M Series B Led by EU Fund
Stockholm-based Tandem Health, a HealthTech startup developing an AI-native operating system for European clinics, has raised $100 million (€86.49 million) in Series B funding. The round was led by EQT's Scaleup Europe Fund, marking its first healthcare investment, with participation from existing investors Kinnevik, Northzone, Amino Collective, and Visionaries. Tandem's AI co-pilot assists clinicians by generating medical notes, preparing patient summaries, aiding clinical decisions, and automating documentation; it is certified as a Class IIa medical device under EU regulations. Used by over 10,000 care organizations across 14 European markets, including the NHS, Ramsay Santé, and Humanitas, the company has now raised a total of $160 million following a $50 million Series A last year. The funding will support European expansion, growth of its clinician-led team, and the evolution into a comprehensive AI-native clinic operating system.
a16z Eyes European Startups for Next Big Investment
Andreessen Horowitz (a16z) led a $2.3 million pre-seed round in Dentio, a Stockholm-based startup that uses large language models to automate dentists’ administrative work, including an AI recording tool that generates clinical notes. Gabriel Vasquez, an a16z partner who focuses on AI applications, has frequently visited Stockholm to source early-stage European deal flow; a16z recently announced new funds totaling $15 billion. Dentio — founded by Elias Afrasiabi, Anton Li and Lukas Sjögren and an alum of SSE Business Lab and KTH’s Innovation Launch — emphasizes EU data compliance by processing relevant data in Sweden and Finland. The seven-person team plans European and international expansion. Tandem Health is cited as a potential competitor after its $50M Series A last year.
Healthleap Raises $38M for AI-Powered Hospital Patient Screening
Healthleap, a startup using AI to analyze patient records, has raised $38 million in seed and Series A funding. The round includes an $8 million seed co-led by Sequoia Capital and First Round Capital, and a $30 million Series A led by Hummingbird Ventures. The platform, deployed in over 50 hospitals, screens patients for conditions like malnutrition and delirium by extracting clinical concepts from clinician notes. Customers include Penn Medicine, Cedars-Sinai, and others. Revenue has grown over 10x in the past year. Funding will support expansion into more health conditions and outpatient care.
Receive all future signals for Deutsche Telekom & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.